Seguir
Rossella Marullo
Rossella Marullo
Weill Cornell Medicine
Dirección de correo verificada de med.cornell.edu
Título
Citado por
Citado por
Año
Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions
R Marullo, E Werner, N Degtyareva, B Moore, G Altavilla, SS Ramalingam, ...
PloS one 8 (11), e81162, 2013
7752013
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
F Cayrol, P Praditsuktavorn, TM Fernando, N Kwiatkowski, R Marullo, ...
Nature communications 8 (1), 14290, 2017
1022017
HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer …
R Marullo, E Werner, H Zhang, GZ Chen, DM Shin, PW Doetsch
Carcinogenesis 36 (11), 1397-1406, 2015
972015
Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas
B Culjkovic-Kraljacic, TM Fernando, R Marullo, N Calvo-Vidal, A Verma, ...
Blood, The Journal of the American Society of Hematology 127 (7), 858-868, 2016
902016
Combinatorial epigenetic therapy in diffuse large B cell lymphoma pre-clinical models and patients
B Pera, T Tang, R Marullo, SN Yang, H Ahn, J Patel, R Elstrom, J Ruan, ...
Clinical Epigenetics 8, 1-10, 2016
442016
Combination therapy targeting BCL6 and phospho-STAT3 defeats intratumor heterogeneity in a subset of non–small cell lung cancers
D Deb, S Rajaram, JE Larsen, PD Dospoy, R Marullo, LS Li, K Avila, ...
Cancer research 77 (11), 3070-3081, 2017
412017
BCL6 evolved to enable stress tolerance in vertebrates and is broadly required by cancer cells to adapt to stress
TM Fernando, R Marullo, B Pera Gresely, JM Phillip, SN Yang, ...
Cancer discovery 9 (5), 662-679, 2019
352019
Metabolomic profiling reveals cellular reprogramming of B-cell lymphoma by a lysine deacetylase inhibitor through the choline pathway
B Pera, J Krumsiek, SE Assouline, R Marullo, J Patel, JM Phillip, L Román, ...
EBioMedicine 28, 80-89, 2018
282018
The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases
R Marullo, M Castro, S Yomtoubian, MN Calvo-Vidal, MV Revuelta, ...
Science advances 7 (45), eabg1964, 2021
222021
Oncogenic HSP90 facilitates metabolic alterations in aggressive B-cell lymphomas
MN Calvo-Vidal, N Zamponi, J Krumsiek, MA Stockslager, MV Revuelta, ...
Cancer research 81 (20), 5202-5216, 2021
202021
Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma
E Ricker, A Verma, R Marullo, S Gupta, C Ye, T Pannellini, M Manni, ...
Scientific Reports 10 (1), 13094, 2020
92020
Procedure for developing linear and Bayesian classification models based on immunosensor measurements
S Mobley, S Yalamanchili, H Zhang, R Marullo, ZG Chen, CS Moreno, ...
Sensors and Actuators B: Chemical 190, 165-170, 2014
82014
Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas
R Marullo, SC Rutherford, JP Leonard, L Cerchietti
Cell Cycle 15 (17), 2241-2247, 2016
52016
Abstract LB-062: XPO1 is a rational target for double and triple-hit aggressive B-cell lymphomas
R Marullo, SN Yang, T Rashal, Y Landesman, R Carlson, S Shacham, ...
Cancer research 75 (15_Supplement), LB-062-LB-062, 2015
52015
A phase I study of selinexor and R-ICE in patients with relapsed/refractory aggressive B-cell lymphomas
SC Rutherford, JN Allan, J Ruan, RR Furman, K Richards, A Rodriguez, ...
Blood 136, 7-8, 2020
42020
XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells
R Marullo, SC Rutherford, MV Revuelta, N Zamponi, B Culjkovic-Kraljacic, ...
Cancer Research 84 (1), 101-117, 2024
32024
The transcription factor BCL6 is a rational target in non-small cell lung cancer (NSCLC)
R Marullo, H Ahn, M Cardenas, A Melnick, F Xue, L Cerchietti
Cancer Research 76 (14_Supplement), 1271-1271, 2016
32016
Inhibition of integrin αVβ3 signaling improves the antineoplastic effect of bexarotene in cutaneous T-cell lymphoma
F Cayrol, MV Revuelta, M Debernardi, A Paulazo, JM Phillip, N Zamponi, ...
Molecular cancer therapeutics 21 (9), 1485-1496, 2022
22022
Aging-Associated Epigenetic Reprogramming Alters the Germinal Center Reaction and Targets Pathways Related to Lymphomagenesis
R Marullo, MV Revuelta, W Béguelin, J Lara-Garcia, L Cerchietti
Blood 138, 676, 2021
22021
Development of a Novel Class of Microtubule Destabilizing Agents with Selectivity Against Diffuse Large B-Cell Lymphoma (DLBCL) with B-Cell Receptor (BCR) Activation
BP Gresely, F de Asís Balaguer, MG Cardenas, MV Revuelta, MNC Vidal, ...
Blood 130, 2546, 2017
22017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20